Click on “+” next to each header to access more information you and your practice can use about COVID-19.
NEWS ON RHEUMATOLOGY MATTERS – COVID 19 ISSUE
To access the News on Rheumatology Matter – COVID 19 issue – click here
Paycheck Protection Program Loans – article
ACR – Guiding Principles on Urgent vs Non-Urgent Services – handout
CARES Act Provider Relief Fund – website
CARES Act Provider Relief Fund Payment Attestation Portal – website
Track Your Employee Each Day – handout
CDC Get Your Clinic Ready – handout
Hart Heath Strategies Resources for Small Businesses – handout
Hart Health Strategies Federal Relief Information – article
CMS Announces Relief for MIPS and other Programs – article
CMS announces expansion of Accelerated and Advance Payment Program for Medicare providers and suppliers – handout
Small Business Administrations’s 7(a) loan program – article
Frequently asked questions (FAQ) document prepared by congressional staff on the Phase III coronavirus legislation – the CARES Act – handout
Physician Provisions in CARES Act – article
Tax provisions in CARES Act – article
Small Business Paycheck Protection – Summary – article
Small Business Paycheck Protection Program FAQ resource page – article
State Resources Regarding the COVID-19 Pandemic – handout
The Complete programs are always available to support new and continuing patients with product education and access support. AbbVie’s Complete resources are full operational. By contacting the product’s complete program you can also learn about the new MyAbbVie Assist Interim Assistance program. This resource will provide medication at no charge for people who have recently lost their job and no longer have commercial insurance coverage.
HUMIRA Complete: 1-800-4HUMIRA (1-800-448-6472)
RINVOQ Complete: 1-800-2RINVOQ (1-800-274-6867)
BMS expanded their patient support program to provide free medication to those that have lost their job or are from another country and are unable to return home to access their medications.
For additional information click here.
COVID-19 Emergency Food Assistance Program funded by the Bristol Myers Squibb Foundation.
For additional information click here.
Horizon Therapeutics update.
Patient Assistance information.
ucbCARES stands ready to help anyone impacted by COVID-19 find answers to their questions and ensuring they receive the respect and care they deserve during this concerning time. Our team is able to provide information related to UCB products as well as our expanded patient assistance programs for those impacted by COVID-19.
Additional information on UCB’s response, including on our supply chain and clinical trials is available here: https://ucb-usa.com/stories-media/UCB-U-S-News/detail/article/UCB-Statement-on-COVID-19-Outbreak
As a reminder, Janssen CarePath continues to offer programs supporting patients with different needs: For eligible commercially insured patients starting or continuing on certain Janssen medicines, programs that help patients lower their out-of-pocket costs; For patients who have lost their jobs and insurance coverage, Janssen CarePath can provide a referral to independent foundations that offer free medicines; and for new patients starting on most Janssen medicines, free trial product programs
Understanding the Families Coronavirus Response Act Q&A Webinar – Webinar
Scott Warwick, JD, MLHR, CEQC, SHRM-SCP website for Coronavirus information include two current files on Healthcare Workers and Responders the Families Response Act and Providers with less than 50 employees and the Families Response Act – Website
Trump Signs Coronavirus Relief Bill with Paid-Leave Mandate – article
Family Medical Leave Act – https://www.dol.gov/agencies/whd/fmla/pandemic
Sequence for Putting On Personal Protective Equipment handout
Personal Protective Equipment- handout
Interim Infection and Disease Control – handout
Return to Work Criteria – article
Health Care Workers on the Front Lines – handout
COVID Vaccine Document
On February 11, 2021, the ACR released guidelines when it comes to the COVID19 vaccine and our medications. For our practice, this affects patients who are on MTX, JAK Inhibitors, Rituxan, and Orencia. (https://www.rheumatology.org/About-Us/Newsroom/Press-Releases/ID/1138)
Hold MTX 1 week after each vaccine dose, for those with well-controlled disease; no modifications to vaccination timing.
Hold JAKi for 1 week after each vaccine dose; no modification to vaccination timing.
Hold SQ abatacept both one week prior to and one week after the first
COVID-19 vaccine dose (only); no interruption around the second
Time vaccine administration so that the first vaccination will occur
four weeks after abatacept infusion (i.e., the entire dosing interval),
and postpone the subsequent abatacept infusion by one week (i.e., a
5-week gap in total); no medication adjustment for the second vaccine
Time CYC administration so that it will occur approximately 1 week
after each vaccine dose, when feasible.
Assuming that patient’s COVID-19 risk is low or is able to be mitigated
by preventive health measures (e.g., self-isolation), schedule
vaccination so that the vaccine series is initiated approximately 4
weeks prior to next scheduled rituximab cycle; after vaccination, delay
RTX 2-4 weeks after 2nd vaccine dose, if disease activity allows.
PANEL DISCUSSION: THE CARES ACT and OTHER FINANCIAL ASSISTANCE
Panel Discussion: The CARES Act and Other Financial Assistance For Your Practice
Tuesday, April 21 from 2pm – 4pm EDT
Join us as a panel of experts in healthcare business consulting discuss the benefits and risks of various financial and tax assistance programs, most of which are provided through the recently passes CARES.
Toby D. Clary, CPA, CVA
Shareholder, Soukup, Bush & Associates
Amanda L. Waesch, JD
Executive Committee, BMD LLC
Sean M. Weiss, CHC, CEMA, CMCO, CPMA, CPC-P, CMPE, CPC
Partner & Vice President of Compliance, Doctors Management
David J. Zetter, PHR, SHRM-CP, CHCC, CPCO, CPC, COC, PCS, FCS, CHBC, CMUP, PESC, CMAP, CMAPA, CMMP
Founder, Zetter Healthcare Management Consultants
President-Elect, National Society of Certified Healthcare Business Consultants
President, National Organization of Rheumatology Managers
Board Member, National Organization of Rheumatology Managers
To view the Panel Discussion Recording click here.
To view the panel discussion slide deck click here.
NORM Telehealth Webinar presented by Jean Acevedo – website
This website also contains handouts used in then Webinar.
Remember that the data included in this webinar was accurate as of the time webinar.
Telemedicine, Virtual Visits & Digital E/M Services Update Webinar Attendee Q&A Summary – handout
TeleHealth (MDM and Time) Clearing Up The Confusion, by Sean Weiss DoctorsManagement – article
There is a Pandemic (DoctorsManagement) – article
Hart Health Telehealth payments in Response to COVID19 Pandemic – article
Hart Health Strategies Telehealth Information (Summary of CMS changes) – article
CMS – Medicare Telehealth Frequently Asked Questions – handout
CMS – Medicare TeleMedicine Health Care Provider Fact Sheet – article
AMA applauds Medicare telemedicine change – article
AMA Quick Guide to telemedicine – article
Medicare Coverage and Payment Related COVID – handout
Vendor Options – article
ACR Fact Sheet – article
United Healthcare Extends Temporary Telehealth Expansion and Reimbursement Through
Sept. 30, 2020 – article
American Rheumatology Network- resources
DoctorsManagement Resource Center – article
NICA Toolkit – https://infusioncenter.org/covid-19/
Responding to COVID19 – Cardinal Health – https://attendee.gotowebinar.com/recording/6322219754055508494
Respond to COVID19 – Cardinal Health – Slides
CDC COVID19 Resources – website
National Alliance of Medical Auditing Specialist COVID19 resource site – website
NC Department of Health & Human Services – Interim Guide for Discontinuation of Home Isolation – Instructions
NC Department of Health & Human Services – Outpatient Triage Assessment Guidelines – handout
MetroMedical Letter regarding distribution – handout